产品: VCAM1 抗体
货号: DF6082
来源: Rabbit
应用: WB, IHC, IF/ICC, ELISA(peptide)
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Rabbit, Dog
分子量: 80~120kD; 81kD(Calculated).
蛋白号: P19320
RRID: AB_2838050

浏览相似产品>>

   规格 价格 库存
 50ul ¥1250 现货
 100ul ¥2300 现货
 200ul ¥3000 现货

货期: 当天发货

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat
预测:
Pig(82%), Bovine(82%), Horse(100%), Rabbit(91%), Dog(82%)
克隆:
Polyclonal
特异性:
VCAM1 Antibody detects endogenous levels of total VCAM1.
RRID:
AB_2838050
引用格式: Affinity Biosciences Cat# DF6082, RRID:AB_2838050.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

CD106; CD106 Antigen; INCAM 100; INCAM-100; L1CAM; MGC99561; V-CAM 1; Vascular Cell Adhesion Molecule 1; Vascular cell adhesion protein 1; VCAM 1; VCAM-1; VCAM1; VCAM1_HUMAN;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
表达特异性:
P19320 VCAM1_HUMAN:

Expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflamed tissue.

蛋白描述:
Vascular cell adhesion protein 1 (VCAM1) is important in cell-cell recognition. It has been reported to function in leukocyte-endothelial cell adhesion, interact with the beta-1 integrin VLA4 on leukocytes, and mediate both adhesion and signal transduction. There are two isoforms; Isoform 1, a single-pass type I membrane protein, and isoform 2, a lipid-anchor (GPI-anchor). VCAM1 is expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflamed tissue. It is also expressed in the bone marrow (1).
蛋白序列:
MPGKMVVILGASNILWIMFAASQAFKIETTPESRYLAQIGDSVSLTCSTTGCESPFFSWRTQIDSPLNGKVTNEGTTSTLTMNPVSFGNEHSYLCTATCESRKLEKGIQVEIYSFPKDPEIHLSGPLEAGKPITVKCSVADVYPFDRLEIDLLKGDHLMKSQEFLEDADRKSLETKSLEVTFTPVIEDIGKVLVCRAKLHIDEMDSVPTVRQAVKELQVYISPKNTVISVNPSTKLQEGGSVTMTCSSEGLPAPEIFWSKKLDNGNLQHLSGNATLTLIAMRMEDSGIYVCEGVNLIGKNRKEVELIVQEKPFTVEISPGPRIAAQIGDSVMLTCSVMGCESPSFSWRTQIDSPLSGKVRSEGTNSTLTLSPVSFENEHSYLCTVTCGHKKLEKGIQVELYSFPRDPEIEMSGGLVNGSSVTVSCKVPSVYPLDRLEIELLKGETILENIEFLEDTDMKSLENKSLEMTFIPTIEDTGKALVCQAKLHIDDMEFEPKQRQSTQTLYVNVAPRDTTVLVSPSSILEEGSSVNMTCLSQGFPAPKILWSRQLPNGELQPLSENATLTLISTKMEDSGVYLCEGINQAGRSRKEVELIIQVTPKDIKLTAFPSESVKEGDTVIISCTCGNVPETWIILKKKAETGDTVLKSIDGAYTIRKAQLKDAGVYECESKNKVGSQLRSLTLDVQGRENNKDYFSPELLVLYFASSLIIPAIGMIIYFARKANMKGSYSLVEAQKSKV

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Horse
100
Rabbit
91
Pig
82
Bovine
82
Dog
82
Chicken
70
Sheep
0
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - P19320 作为底物

Site PTM Type Enzyme
S465 Phosphorylation
N561 N-Glycosylation
Y653 Phosphorylation
Y703 Phosphorylation
S706 Phosphorylation
S707 Phosphorylation
Y718 Phosphorylation

研究背景

功能:

Important in cell-cell recognition. Appears to function in leukocyte-endothelial cell adhesion. Interacts with integrin alpha-4/beta-1 (ITGA4/ITGB1) on leukocytes, and mediates both adhesion and signal transduction. The VCAM1/ITGA4/ITGB1 interaction may play a pathophysiologic role both in immune responses and in leukocyte emigration to sites of inflammation.

翻译修饰:

Sialoglycoprotein.

细胞定位:

Membrane>Single-pass type I membrane protein.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
组织特异性:

Expressed on inflamed vascular endothelium, as well as on macrophage-like and dendritic cell types in both normal and inflamed tissue.

蛋白家族:

Either the first or the fourth Ig-like C2-type domain is required for VLA4-dependent cell adhesion.

研究领域

· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway.   (View pathway)

· Environmental Information Processing > Signaling molecules and interaction > Cell adhesion molecules (CAMs).   (View pathway)

· Environmental Information Processing > Signal transduction > TNF signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Parasitic > African trypanosomiasis.

· Human Diseases > Infectious diseases: Parasitic > Malaria.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Organismal Systems > Immune system > Leukocyte transendothelial migration.   (View pathway)

文献引用

1). Chen X et al. Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin β1-RhoA-JNK signaling activation. J Cell Physiol 2018 Dec 10 (PubMed: 30536538) [IF=6.513]

Application: WB    Species: human    Sample: HUVECs cells

FIGURE 6| Gal‐3 induced expression of inflammatory factors promoted HUVECs injury via integrin β1‐RhoA‐JNK pathway. HUVECs,exposing to the ox‐LDL alone or in combination with Gal‐3 were further treated with integrin β1‐siRNA or JNK inhibitor (SP600125). The total and phosphorylated expression of p65,IKKα and IKKβ after the above treatment was examined by WB and demonstrated by histogram. (a and b).The levels of inflammatory cytokines and chemokines were then measured by ELISA. (c and d) The expression of adhesion molecules (ICAM‐1 and VCAM‐1) was detected by WB (e). *p < 0.05, **p < 0.01

2). Huang S et al. Nepeta angustifolia attenuates responses to vascular inflammation in high glucose-induced human umbilical vein endothelial cells through heme oxygenase-1 induction. J Ethnopharmacol 2019 Mar 1;231:187-196 (PubMed: 30419276) [IF=5.195]

3). Hu R et al. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol 2020 Jan 15;867:172797 (PubMed: 31747547) [IF=5.195]

Application: WB    Species: human    Sample: HUVECs

Fig. 8. |An AMPK inhibitor abrogated the protective effect of salidroside against inflammation in AGEs-induced HUVECs.(A) Representative western blot results for AMPK/NF-κB p65/NLRP3 signaling pathway proteins in AGEs/salidroside treated-HUVECs with or without compound C.GAPDH was used as a loading control. (B) Histograms analysis of the western blot results. The data are representative of one experiment performed in triplicate and are expressed as the mean ± S.D.

4). Smith AO et al. Novel Strategy for Isolation of Mice Bone Marrow–Derived Endothelial Cells (BMECs). Stem Cell Res Ther 2021 May 3;12(1):267. (PubMed: 33941266) [IF=5.116]

Application: WB    Species: mouse    Sample: primary bone marrow endothelial cells

Fig. 4 |Characterization of primary bone marrow endothelial cells by RT-QPCR and immunoblottinge .The immunoblotting analysis of primary bone marrow endothelial after 7 days of cultured further substantiates the purity of endothelial cells with protein ladder (M) (N= 3 indicates independent experiments for RT-qPCR and N=2 for immunoblotting with six mice/group(12 femora and 12 tibias). *p<0.05 **p<0.01, and ***p<0.001

Application: WB    Species: Mice    Sample: bMECs

Fig. 4 Characterization of primary bone marrow endothelial cells by RT-QPCR and immunoblotting: a–d the relative mRNA expression of primary bone marrow endothelial cells compared to CD31 microbead-negative selected cells. The bar chart indicated the fold of the gene expression of primary BMECs compared to the CD31 microbead-negative selected cells. The fold change is quantified by the Pitfall method, followed by a Student’s test comparison between the CD31 microbead-negative selected cells and endothelial cells. P value ≤0.05 considered being statistically significant. e The immunoblotting analysis of primary bone marrow endothelial after 7 days of cultured further substantiates the purity of endothelial cells with protein ladder (M) (N= 3 indicates independent experiments for RT-qPCR and N=2 for immunoblotting with six mice/group (12 femora and 12 tibias). *p<0.05 **p<0.01, and ***p<0.001

5). Wang X et al. Therapeutic effect and mechanism of 4‑phenyl butyric acid on renal ischemia‑reperfusion injury in mice. Exp Ther Med 2022 Feb;23(2):144. (PubMed: 35069825) [IF=2.751]

Application: WB    Species: mouse    Sample: kidneys

Figure 4. |Western blotting analysis of the expression levels of ICAM‑1 and VCAM‑1 in mouse kidneys following ischemia‑reperfusion, DEX and 4‑PBA treat‑ment. The right panel presents representative western blotting, and the left panel shows the relative expression levels. *P<0.05 vs. control; #P<0.05 vs. model.DEX, dexmedetomidine; 4‑PBA, 4‑phenylbutyric acid; ICAM‑1, intercellular adhesion molecule‑1; VCAM‑1, vascular adhesion molecule‑1.

Application: IHC    Species: mouse    Sample: kidneys

Figure 5.| Immunohistochemistry assessment of the expression levels of ICAM‑1 and VCAM‑1 in mice following ischemia‑reperfusion and DEX and 4‑PBA treatment (magnification, x400). The upper panel presents immunohistochemistry results, and the lower panel shows the quantified relative expression levels.*P<0.05 vs. control; #P<0.05 vs. model; ^P<0.05 vs. model + DEX. DEX, dexmedetomidine; 4‑PBA, 4‑phenylbutyric acid; ICAM‑1, intercellular adhesion molecule‑1; VCAM‑1, vascular adhesion molecule‑1.

Application: WB    Species: Mouse    Sample: kidneys

Figure 4 Western blotting analysis of the expression levels of ICAM-1 and VCAM-1 in mouse kidneys following ischemia-reperfusion, DEX and 4-PBA treatment. The right panel presents representative western blotting, and the left panel shows the relative expression levels. *P<0.05 vs. control; #P<0.05 vs. model. DEX, dexmedetomidine; 4-PBA, 4-phenylbutyric acid; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular adhesion molecule-1.

Application: IHC    Species: Mouse    Sample: kidneys

Figure 5 Immunohistochemistry assessment of the expression levels of ICAM-1 and VCAM-1 in mice following ischemia-reperfusion and DEX and 4-PBA treatment (magnification, x400). The upper panel presents immunohistochemistry results, and the lower panel shows the quantified relative expression levels. *P<0.05 vs. control; #P<0.05 vs. model; ^P<0.05 vs. model + DEX. DEX, dexmedetomidine; 4-PBA, 4-phenylbutyric acid; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular adhesion molecule-1.

6). Chai Y et al. Protective Effects of Angong Niuhuang Pill on Early Atherosclerosis in ApoE-/- Mice by Reducing the Inflammatory Response. Evid Based Complement Alternat Med 2019 May 20;2019:9747212 (PubMed: 31236126) [IF=2.650]

7). Yao Y et al. FebuxostatAlleviatesAllergicRhinitis by Inhibiting Inflammation and Monocyte Adhesion in Human Nasal Epithelial Cells via Regulating KLF6. Evid Based Complement Alternat Med 2022 Sep 8;2022:9092311. (PubMed: 36118091) [IF=2.650]

8). Jia Z et al. Ticagrelor and clopidogrel suppress NF-κB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells. BMC Cardiovasc Disord 2019 Dec 30;19(1):318 (PubMed: 31888640) [IF=2.174]

Application: WB    Species: human    Sample: HUVECs

Fig. 4 Ticagrelor and clopidogrel restored the LPS-caused reduced ability of HUVECs to form tubular networks. HUVECs were incubated with DMSO (as a control), ticagrelor (20 μM), clopidogrel (20 μM), DMSO plus LPS (10 ng/mL) and CD14 (1 μg/mL), ticagrelor (20 μM) plus LPS (10 ng/mL) and CD14 (1 μg/mL), and clopidogrel (20 μM) plus LPS (10 ng/mL) and CD14 (1 μg/mL), separately, for 16 h. Then, the cell lysates were immunoblotted with the indicated antibodies

9). A novel UV-curable extravascular stent to prevent restenosis of venous grafts.

10). Developing physiological 3D in vitro tissue models for rheumatology research.

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.